Online citations, reference lists, and bibliographies.
← Back to Search

The Search For Low-penetrance Cancer Susceptibility Alleles

R. Houlston, J. Peto
Published 2004 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Much of the familial aggregation of common cancer results from inherited susceptibility, but highly penetrant mutations in known genes cannot account for most of the excess. Some of the unexplained familial risk is presumably due to high-penetrance mutations in as yet unidentified genes, but polygenic mechanisms are likely to account for a greater proportion, particularly in breast cancer. This inference, coupled with technological developments, has led to a renaissance in association studies. Most such studies have evaluated small numbers of single-nucleotide polymorphisms (SNPs) in a few candidate genes, but reliable high-density oligonucleotide arrays and other novel techniques will allow genome-wide allelic association studies to be conducted. High-density genome-wide SNP analysis will include targets identified by structural considerations, as well as the growing list of candidate genes. In the longer term, high-throughput re-sequencing will be required to identify the rare pathogenic variants that may constitute the majority of low-penetrance alleles. The detection of low-penetrance cancer susceptibility genes will then be restricted mainly by the availability of large numbers of well-characterized cases and controls. Cancer patients with affected relatives are considerably more informative than unselected cases for such studies.
This paper references
Int
J Peto (1996)
Cancer Epidemiol
AM Dunning (1999)
Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
A. Feyler (2002)
10.1097/00008571-199806000-00005
Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease.
A. Rostami-Hodjegan (1998)
10.1126/SCIENCE.2270482
Linkage of early-onset familial breast cancer to chromosome 17q21.
J. M. Hall (1990)
Hum
MM DeMille (2002)
10.1056/NEJM200007133430201
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P. Lichtenstein (2000)
10.1126/SCIENCE.8484120
Genetic mapping of a locus predisposing to human colorectal cancer.
P. Peltomäki (1993)
10.1093/CARCIN/23.8.1343
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk.
S. Benhamou (2002)
10.1002/1097-0142(197410)34:4<1090::AID-CNCR2820340419>3.0.CO;2-J
Genetic study of breast cancer: Identification of a high risk group
D. E. Anderson (1974)
Nat
A Lindbolm (1993)
10.1086/301749
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D. Ford (1998)
Proc
NE Morton (2001)
Banbury Report 4: Cancer Incidence In Defined Populations Cairns J, Lyon JL and Skolnick MH (eds) Cold Spring Harbor Laboratories: Cold Spring Harbor, New York, pp
J. Peto (1980)
10.1053/GAST.2001.26265
Polymorphisms and colorectal tumor risk.
R. Houlston (2001)
10.1073/pnas.091062198
The optimal measure of allelic association
N. Morton (2001)
10.1126/SCIENCE.8091231
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R. Wooster (1994)
Nat
MR Stratton (2000)
Cancer Epidemiol
C Ntais (2003)
10.1038/328614A0
Localization of the gene for familial adenomatous polyposis on chromosome 5
W. Bodmer (1987)
Cancer Epidemiol
A Feyler (2002)
10.1515/9783111438443-006
N
Città DI Torino (1824)
Nat
PD Pharoah (2002)
Br
Anglian Breast Cancer Study Group (2000)
Am
JK Pritchard (2000)
Hum
RS Houlston (2003)
10.1097/00008571-200003000-00003
NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.
P. Marcus (2000)
10.1126/SCIENCE.1439824
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.
L. Cannon-Albright (1992)
Nat
L. Kruglyak (1999)
Hum
A Collins (2001)
SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis.
C. Ntais (2003)
Nat
J Peto (2000)
10.1126/science.273.5281.1516
The Future of Genetic Studies of Complex Human Diseases
N. Risch (1996)
Nat
D Botstein (2003)
Am
NJ Lench (2000)
Am
M Hedman (1998)
Environ
A Weston (1997)
A systematic review of genetic polymorphisms and breast cancer risk.
A. Dunning (1999)
Am
AM Dunning (2000)
Banbury Report 4: Cancer Incidence In Defined Populations
J Peto (1980)
10.1016/S1535-6108(02)00079-X
Breast cancer susceptibility-A new look at an old model.
J. Peto (2002)
10.1086/316906
The extent of linkage disequilibrium in four populations with distinct demographic histories.
A. Dunning (2000)
Nat
J Mangion (2002)
Genet
AC Antoniou (2003)
10.1086/316944
Extent and distribution of linkage disequilibrium in three genomic regions.
G. Abecasis (2001)
10.1086/302959
Association mapping in structured populations.
J. Pritchard (2000)
Cancer Epidemiol
P Peltomaki (2003)
10.1177/003591576806100226
Pharmacogenetics
G. H. Bush (1968)
10.1086/421251
CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.
D. Easton (2004)
10.1038/35075590
Linkage disequilibrium in the human genome
David E. Reich (2001)
10.1002/HUMU.21
Allelic association with SNPs: Metrics, populations, and the linkage disequilibrium map
A. Collins (2001)
10.1038/sj.onc.1203283
DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis
G. K. Dasika (1999)



This paper is referenced by
10.1186/bcr1389
Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer
Nigel P. S. Crawford (2005)
10.1093/JNCI/DJM140
MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Stavroula R Raptis (2007)
10.1158/1055-9965.EPI-08-0513
PTPRJ Haplotypes and Colorectal Cancer Risk
A. Toland (2008)
10.1158/1055-9965.EPI-05-0234
p53 Genotypes and Risk of Glioma and Meningioma
B. Malmer (2005)
10.1002/ijc.22693
Role of S128R polymorphism of E‐selectin in colon metastasis formation
R. Alessandro (2007)
10.1186/1471-2407-9-438
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
R. J. Hartmaier (2009)
cancers : actualités et perspectives
D. Stoppa-Lyonnet (2005)
10.1016/j.semradonc.2007.10.003
From cellular to high-throughput predictive assays in radiation oncology: challenges and opportunities.
S. Bentzen (2008)
NOD 2 / CARD 15 variants in Malaysian patients with sporadic colorectal cancer
T. P. Lau (2014)
10.1002/ijc.23848
Family history of cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
E. Negri (2009)
10.1667/RR3400
Influence of Polymorphisms in DNA Repair Genes XPD, XRCC1 and MGMT on DNA Damage Induced by Gamma Radiation and its Repair in Lymphocytes In Vitro
J. Rzeszowska-Wolny (2005)
10.1093/CARCIN/BGM229
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer.
M. Mrkonjic (2007)
10.1007/s10689-010-9372-3
Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer
L. Cavallone (2010)
10.1007/s11033-011-1217-0
Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma
W. Guo (2011)
10.1016/j.mad.2008.03.005
Use of elderly tumor-free subjects as a “supercontrol” for cancer epidemiological studies: pros and cons
E. Imyanitov (2009)
10.1007/978-0-387-93846-2_14
The HapMap Project and Low-Penetrance Cancer Susceptibility Alleles
Edwin Choy (2010)
Diet, lifestyle, heritable factors and colorectal carcinogenesis: associations with histopathological and molecular endpoints
P. Wark (2007)
10.1093/CARCIN/BGL253
The molecular epidemiology of lung cancer.
A. Schwartz (2007)
10.1155/2005/737191
Genetic Predisposition to Sporadic Cancer: How to Handle Major Effects of Minor Genes?
R. Fijneman (2005)
10.1155/2011/172678
Cigarette Smoke and Cancer
S. Kachhap (2011)
10.1530/JME-11-0005
Association studies in thyroid cancer susceptibility: are we on the right track?
I. Landa (2011)
10.1002/gcc.22162
Variants in the ATM‐CHEK2‐BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma
A. Wójcicka (2014)
10.1016/j.canlet.2008.02.021
ARLTS1 - a novel tumor suppressor gene.
S. Yendamuri (2008)
CHEK2 1100delC and polygenic susceptibility to breast cancer and colorectal cancer
Marijke Wasielewski (2009)
10.1007/978-3-319-41388-4_13
Common Variants Confer Susceptibility to Barrett's Esophagus: Insights from the First Genome-Wide Association Studies.
C. Palles (2016)
10.1158/1055-9965.EPI-05-0512
No Evidence of False Reassurance among Women with an Inconclusive BRCA1/2 Genetic Test Result
M. Dorval (2005)
10.3748/wjg.v17.i41.4640
Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma.
Marcin Krawczyk (2011)
10.1016/j.cdp.2008.06.003
The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.
G. De Vecchi (2008)
Population-based family studies: Genetic contribution to cancer development and survival?
L. Lindström (2008)
Genetic Predictors of Clinical Outcomes in Non-Small Cell Lung Cancer Patients
Xia Pu (2012)
10.1093/jnci/djn037
Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.
B. Frank (2008)
Pharmacogenetic screening of docetaxel, irinotecan and fluoropyrimidines in cancer therapy
T. Bosch (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar